feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Patel Engineering wins ₹798 crore order

trending

Whirlpool shares crash on reports

trending

Mars rover detects electrical sparks

trending

Comet ATLAS explodes into pieces

trending

Sensex, Nifty near record highs

trending

CTET 2026 Registration Begins

trending

RRB NTPC registration closes today

trending

Cyclone Ditwah intensifies over Bengal

trending

Shein faces EU scrutiny

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Boy's life-changing gene therapy trial offers new hope

Boy's life-changing gene therapy trial offers new hope

24 Nov

•

Summary

  • A pioneering gene therapy trial is offering new hope for children with Hunter syndrome.
  • The experimental treatment involves modifying a patient's own stem cells.
  • Hunter syndrome is a rare genetic disorder affecting one in 100,000 male births.
Boy's life-changing gene therapy trial offers new hope

Scientists in the UK have developed a pioneering gene therapy trial offering a new lifeline to children battling Hunter syndrome. This rare genetic disorder, affecting about one in 100,000 male births globally, typically manifests in early childhood with symptoms ranging from physical abnormalities to severe cognitive decline.

The groundbreaking treatment involves a complex process where a patient's stem cells are collected, genetically modified in a laboratory, and then returned to the body. This innovative approach aims to halt the disease's progression, offering a potential one-off cure where previous treatments could only manage physical symptoms.

The medical trial, nearly derailed by funding issues, is now giving children like Oliver a chance at a healthier future. This cutting-edge therapy represents a significant advancement in the fight against rare genetic conditions, moving beyond symptom management to target the root cause.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Hunter syndrome is a rare genetic disorder affecting boys, causing progressive physical and neurological damage. Treatment is now exploring gene therapy alongside existing methods that manage physical effects.
The therapy involves modifying a patient's own stem cells in a lab and then reinfusing them to halt the genetic disorder's progression.
The article mentions the trial almost didn't get off the ground due to a lack of funds, highlighting the challenges in developing treatments for rare diseases.

Read more news on

Healthside-arrow

You may also like

Gene Therapy Cures "Bubble Boy Disease"

10 hours ago • 71 reads

article image

Heartburn? It Might Be a Serious Immune Disorder

10 hours ago • 2 reads

article image

ALS: Nerve's Silent Retreat, Muscle's Slow Fade

1 day ago • 5 reads

article image

Medieval Warrior's Skull Baffles Archaeologists

1 day ago • 4 reads

article image

Sonali Bendre's Cancer Claims Spark Doctor Backlash

24 Nov • 8 reads

article image